Lunsumio provides high rates of deep and long-lasting responses in third-line and later follicular lymphoma, a disease that ...

European Commission grants conditional marketing approval for Roche’s Lunsumio subcutaneous for R/R follicular lymphoma: Basel Thursday, November 20, 2025, 12:00 Hrs [IST] Roche ...

Researchers at University Medical Center Maastricht and international partners report that a single shot of the drug ...

Lunsumio provides high rates of deep and long-lasting responses in third-line and later follicular lymphoma, a disease that typically becomes harder to treat each time a patient relapses1,2Lunsumio su ...

No one likes needles. But there are times when they do get under your skin, quite literally, like during vaccination, having your blood drawn for a health check, or getting an aesthetic procedure such ...

NEW ORLEANS -- Patients experiencing major heart attacks had a lower risk of serious complications if they received a single ...

A generic teduglutide reduced parenteral nutrition requirements in 96% of pediatric patients within 24 weeks in clinical ...

WASHINGTON -- Treatment with the investigational GLP-1/glucagon dual receptor agonist pemvidutide led to resolution of ...

Plozasiran is an apoC-III-directed small interfering ribonucleic acid designed to reduce levels of hepatic and serum apoC-III ...

The FDA has approved a new type of medication to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS), a rare disease that causes extremely high triglycerides.

Arrowhead boasts a diversified RNAi pipeline targeting liver, lung, muscle, CNS, and obesity. Read why I recommend buying and ...

The global injection pen market is expected to grow at a rate of 7% over the next five years. Key factors fueling this growth include the rising prevalence of chronic diseases, the increasing demand ...